Skip to Content
Authors Barry MJ, Fowler FJ, O'leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT, Measurement Committee of the American Urological Association
Author Profile(s)
Journal J. Urol. Volume: 197 Issue: 2S Pages: S189-S197
Publish Date 2017 Feb
PubMed ID 28012747
Abstract

A symptom index for benign prostatic hyperplasia (BPH) was developed and validated by a multidisciplinary measurement committee of the American Urological Association (AUA). Validation studies were conducted involving a total of 210 BPH patients and 108 control subjects. The final AUA symptom index includes 7 questions covering frequency, nocturia, weak urinary stream, hesitancy, intermittence, incomplete emptying and urgency. On revalidation, the index was internally consistent (Cronbach’s α = 0.86) and the score generated had excellent test-retest reliability (r = 0.92). Scores were highly correlated with subjects’ global ratings of the magnitude of their urinary problem (r = 0.65 to 0.72) and powerfully discriminated between BPH and control subjects (receiver operating characteristic area 0.85). Finally, the index was sensitive to change, with preoperative scores decreasing from a mean of 17.6 to 7.1 by 4 weeks after prostatectomy (p <0.001). The AUA symptom index is clinically sensible, reliable, valid and responsive. It is practical for use in practice and for inclusion in research protocols.


webmaster@surgery.wisc.edu Copyright © 2017 The Board of Regents of the University of Wisconsin System